喜炎平注射液治疗脑梗死并肺部感染的疗效观察

Efficiency of Xiyanping Injection for Patients With Cerebral Infarction Accompanied by Pulmonary Infection

目的探讨喜炎平注射液治疗脑梗死并肺部感染患者的临床效果。方法选择我院神经内科90例脑梗死并肺部感染患者,随机分为观察组和对照组,对照组给予内科常规治疗,观察组在常规治疗基础上给予喜炎平注射液,观察两组患者治疗效果。结果观察组肺部感染控制时间和退热时间与对照组比较明显缩短,差异有统计学意义(P<0.05),观察组治疗总有效率为84.4%,对照组为53.3%,观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05),观察组较对照组白细胞和中性粒细胞计数降低效果更显著,差异有统计学意义(P<0.05)。结论喜炎平注射液治疗脑梗死并肺部感染患者效果较好,可有效控制感染,安全性高。

Objective To explore the application value of Xiyanping injection in the treatment of cerebral infarction complicated by pulmonary infection.Methods 90 patients with cerebral infarction accompanied by pulmonary infection were randomly divided into observation group （45 cases） and control group （45 cases）, the patients in two groups were given routine medical treatment,in addition,the patients in observation group were given Xiyanping injection, the clinical efficiencies were compared.ResultsPulmonary infection control time and cooling time in observation group were shoter than control group, and the different was statisticaly significant（P 〈 0.05）,the total effective rate of the observation group was 84.4%,which was higher than 53.3% of the control group（P 〈 0.05）,leukocyte and neutrophil counts in observation group were lower than control group（P〈 0.05）.Conclusion Xiyanping injection was effective ,safe and has active anti-infection effects in treatment of cerebral infarction accompanied by pulmonary infection.